Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

ICD-10 Code G14: Postpolio syndrome diagnosis and billing guide

Key Takeaways

Key Takeaways

ICD-10 Code G14 is the billable diagnosis code for postpolio syndrome, classified under systemic atrophies primarily affecting the central nervous system (G10-G14).

G14 and B91 (sequelae of poliomyelitis) are mutually exclusive under a Type 1 Excludes note – use B91 alone for stable residual sequelae, and G14 alone once new symptoms meet full postpolio syndrome criteria; the two codes must never be reported together.

A Type 1 Excludes note means G14 cannot be coded simultaneously with the excluded conditions listed in the tabular, including M89.6 (osteopathy after poliomyelitis).

Pabau’s claims management software helps coding teams apply Type 1 Excludes logic correctly, flagging mutually exclusive code pairs like G14 and B91 before submission.

ICD-10 code G14 is the billable diagnosis code for postpolio syndrome (PPS). This reference guide covers the clinical criteria, coding guidelines, Type 1 Excludes implications, ICD-9-CM crosswalk, and documentation requirements physiatrists, neurologists, and their coding teams need to submit G14 correctly — including its Type 1 Excludes relationship with B91, a code that must never be reported alongside G14.

Postpolio syndrome affects an estimated 25–40% of polio survivors, according to Post-Polio Health International. The condition presents decades after the original infection, making accurate documentation and coding essential for ongoing multidisciplinary care, insurance reimbursement, and longitudinal patient records.

ICD-10 code G14: definition and clinical description

ICD-10 Code G14 is the billable, specific ICD-10-CM diagnosis code for postpolio syndrome. The CDC/NCHS ICD-10-CM tool classifies G14 under chapter G00-G99 (Diseases of the Nervous System), within the subcategory G10-G14: Systemic atrophies primarily affecting the central nervous system.

Postpolio syndrome is defined as a neurological condition characterized by new or worsening neuromuscular symptoms that appear at least 15 years after the patient achieved clinical stability following an initial symptomatic poliomyelitis infection. The hallmark is onset in a patient with a confirmed prior history of paralytic poliomyelitis.

Core clinical features of postpolio syndrome

For G14 to be assigned correctly, the patient’s presentation must reflect the established clinical picture of PPS. Coders should verify documentation against these criteria before assigning the code.

  • New muscle weakness or fatigue in previously affected or unaffected muscle groups
  • Joint and muscle pain not attributable to other orthopedic causes
  • Breathing or swallowing difficulties in patients with prior bulbar polio
  • Cold intolerance and fatigue with exertion, disproportionate to the exertion level
  • Confirmed prior history of symptomatic poliomyelitis, with an intervening stable period of at least 15 years

Progressive muscular atrophy is listed as a synonym for G14 in the ICD-10-CM index, but this applies only in the context of PPS-associated muscular atrophy. It does not refer to progressive spinal muscular atrophy, which is coded to G12.25 (Progressive spinal muscle atrophy). This distinction matters for claim specificity.

Electrodiagnostic testing — EMG and nerve conduction studies — often supports the differential diagnosis when new weakness could stem from an unrelated neuromuscular process. Coders billing these studies alongside G14 should reference the EMG and nerve conduction studies billing guide for correct procedure code selection.

Coding guidelines for ICD-10 code G14

G14 is fully billable and valid for reimbursement as a principal or secondary diagnosis on claims with a date of service on or after October 1, 2015. CMS confirms G14 has remained stable in its current form through the 2026 fiscal year update.

B91 and the Type 1 Excludes relationship with G14

The ICD-10-CM tabular list carries a Type 1 Excludes note between G14 and B91 (sequelae of poliomyelitis). The two codes are mutually exclusive and must never appear on the same claim.

Use B91 alone for a patient with stable residual effects of prior polio and no new symptoms. Use G14 alone once the patient’s new or worsening neuromuscular symptoms meet the full postpolio syndrome criteria.

For claims management software users, building this Type 1 Excludes logic into claim templates — flagging G14 and B91 as mutually exclusive rather than pairing them by default — prevents this class of coding error at submission.

Automate claims through Healthcode
Automate claims through Healthcode

Type 1 Excludes notes: What cannot be coded with G14

G14 carries a Type 1 Excludes note. Under ICD-10-CM convention, a Type 1 Excludes note means the excluded condition is not coded here and should never be coded simultaneously with G14. The excluded conditions are clinically distinct from postpolio syndrome.

Code Description Relationship to G14
M89.6 Osteopathy after poliomyelitis Type 1 Excludes from G14; G14 and M89.6 can never be coded on the same claim — if the patient has osteopathy after poliomyelitis, use M89.6 without G14 for that condition
B91 Sequelae of poliomyelitis Type 1 Excludes from G14; G14 and B91 can never be coded on the same claim — use B91 alone for stable residual sequelae, or G14 alone once new symptoms meet full postpolio syndrome criteria
G12.25 Progressive muscular atrophy (Progressive spinal muscle atrophy) Distinct entity; PPS-associated muscular atrophy is a synonym for G14 only, not this code

Reviewing the full Type 1 Excludes list before submission ensures no excluded code appears on the same claim as G14. Practices serving patients with complex polio histories should build this check into their neurological condition coding workflows.

Pro Tip

Document the specific year of the original polio diagnosis and the date the patient first achieved clinical stability in the medical record. Payers may request this timeline when reviewing G14 claims, particularly for Medicare patients. A clear notation in the problem list eliminates back-and-forth on initial claim submission.

G14 vs. B91: How to choose the correct code

G14 and B91 serve different purposes and carry a Type 1 Excludes relationship — they are mutually exclusive. G14 identifies active postpolio syndrome: new or worsening neuromuscular symptoms in a patient with prior polio. B91 identifies stable sequelae of the original poliomyelitis infection, without those new symptoms. The two codes are never reported on the same claim.

B91 alone is appropriate when the patient presents with residual effects of prior polio but does not yet meet the clinical criteria for a full PPS diagnosis. A patient with stable residual weakness but no new symptoms fits B91 alone. A patient with new-onset fatigue and progressive weakness at least 15 years post-polio fits G14 alone.

For practices managing rehabilitation patients across these presentations, a physical therapy EMR with configurable diagnosis templates reduces the risk of assigning the wrong code for each clinical picture.

Clinical Scenario Correct Code(s) Rationale
New muscle weakness 20 years after stable polio recovery G14 only Meets full PPS criteria; B91 is excluded once G14 applies (Type 1 Excludes)
Stable residual limb weakness, no new symptoms B91 only Residual sequelae without active PPS presentation
Polio-related bone changes (osteopathy) M89.6 (not G14) Type 1 Excludes – M89.6 excludes G14; code osteopathy separately

Streamline your diagnostic code workflows

Pabau helps physiatry and neurology practices manage multi-code submissions, patient documentation, and claim preparation in one place, so your billing team spends less time correcting denials and more time supporting patient care.

Pabau practice management platform

Documentation requirements for postpolio syndrome

Insufficient documentation is the primary reason G14 claims are challenged at audit. Payers require a clinical record confirming the diagnosis meets the ICD-10-CM definition. For practices using medical records management tools, structuring the patient’s problem list to capture both the historical polio diagnosis and the current PPS presentation is essential before any claim is submitted.

Comprehensive EMR & patient record management
Comprehensive EMR & patient record management

What the medical record must include

  • Confirmed prior polio history: date of original infection, whether the infection was paralytic or non-paralytic, and affected regions
  • Stable period documentation: evidence of at least 15 years of neurological stability between the original infection and the current symptom onset
  • New symptom onset: specific symptoms (muscle weakness, fatigue, pain, breathing changes) with onset dates distinct from the original polio sequelae
  • Exclusion of other causes: the clinician’s documented reasoning ruling out musculoskeletal injury, inflammatory myopathy, or other neuromuscular diagnoses
  • Functional impact: how PPS symptoms affect the patient’s daily functioning and care needs, supporting medical necessity for ongoing treatment

A structured intake tool, such as an about me template, can standardize how this history is captured at the first visit and referenced at every follow-up.

Physiatrists and neurologists should record these elements at every relevant encounter, not just at the initial PPS diagnosis. Consistent documentation across visits builds an audit-ready record. Missing documentation of the stable period or new symptom timeline gives payers grounds for a documentation-based denial.

For practices treating PPS patients alongside other neuromuscular conditions, reviewing your team’s approach to related ICD-10-CM diagnostic code reference documentation can reinforce consistent charting habits across all complex diagnoses. Rehabilitation teams coordinating across disciplines may also find guidance in choosing an occupational therapy EMR useful for aligning PT and OT documentation.

Pro Tip

When documenting PPS for the first time in a new patient’s record, create a dedicated problem-list entry that captures the year of original polio, the affected limbs or regions, the year clinical stability was achieved, and the date new symptoms began. This structured baseline entry is referenced in every subsequent claim and reduces audit risk significantly.

ICD-9-CM crosswalk: From code 138 to ICD-10 code G14

Practices transitioning older patient records or working with legacy billing data will encounter the ICD-9-CM equivalent of G14. Understanding this crosswalk is necessary when reviewing historical records, prior authorization histories, or payer correspondence predating the October 2015 ICD-10 transition. See also: compliance documentation for physiotherapy practices.

For guidance on billing neurological injection therapies used in PPS management, see the HCPCS Code J2350 ocrelizumab billing guide.

ICD-9-CM Code Description ICD-10-CM Equivalent Notes
138 Late effects of acute poliomyelitis G14 (approximate) The crosswalk is approximate; ICD-10 G14 is more clinically specific than ICD-9 138

The crosswalk from 138 to G14 is approximate because ICD-9 code 138 covered a broader category of late polio effects, while G14 specifically designates the syndrome with new progressive neuromuscular symptoms. Use a trusted ICD-9 to ICD-10 crosswalk reference to verify legacy code mappings when reviewing pre-2015 records.

Reimbursement and billing context for ICD-10 code G14

G14 supports medical necessity for a range of services used in postpolio syndrome management. Practices typically submit G14 alongside procedure codes for physical therapy evaluations, occupational therapy evaluations, neuromuscular assessments, and pain management visits. Patients with significant limb weakness may also require durable medical equipment such as a knee orthosis to support mobility and reduce fall risk.

Time-based therapy codes billed alongside G14 must also satisfy the Medicare 8-minute rule for unit calculation. Practices new to rehabilitation billing may find a broader overview of physical therapy billing fundamentals useful before layering in diagnosis-specific rules like those for G14.

Practices using digital intake forms can capture the PPS history elements — prior polio year, stable period, new symptom onset — directly from the patient at intake, building the documentation foundation before the clinician opens the chart.

Teams billing for related infusion or injection procedures may also find the HCPCS code J9173 durvalumab billing guide and the HCPCS code J0586 abobotulinumtoxinA billing guide useful references for adjacent neuromuscular billing scenarios.

Common denial triggers for G14 claims

  • Coding G14 and B91 together: submitting both mutually exclusive codes on the same claim triggers an automatic payer edit rejection
  • No stable-period documentation: the patient record lacks evidence of the mandatory 15-year stability window
  • Conflicting excluded codes: submitting G14 alongside a Type 1 Excluded code (such as M89.6) on the same claim
  • Non-specific symptom coding: coding only fatigue or pain rather than the underlying G14 diagnosis, which reduces reimbursement specificity
  • Outdated crosswalk use: submitting ICD-9 code 138 on claims with service dates after October 1, 2015

Practices running audits on denied G14 claims should check for these triggers first. For teams managing sports medicine and rehabilitation software integrations, ensuring the EHR flags G14 and B91 as mutually exclusive in claim templates prevents this class of denial from reaching the payer at all.

Documentation-driven denials are not unique to G14 — time- and complexity-based codes such as CPT Code 99291 critical care services face similarly close audit scrutiny when supporting documentation is incomplete.

The G10-G14 chapter covers systemic atrophies primarily affecting the central nervous system. Several codes in this range appear in postpolio patient records; the table below clarifies each code’s relationship to G14.

Code Description Relationship to G14
G10 Huntington’s disease Same chapter (G10-G14); distinct hereditary condition
G12.25 Progressive muscular atrophy (Progressive spinal muscle atrophy) Not a synonym for G14; distinct etiology
B91 Sequelae of poliomyelitis Type 1 Excludes from G14; mutually exclusive — never code together
M89.6 Osteopathy after poliomyelitis Type 1 Excludes from G14; never code simultaneously

Conclusion

Most G14 claim denials trace to submitting the code alongside a Type 1 Excluded code such as B91 or M89.6, or to missing documentation of the stable period and new symptom onset. When the clinical record captures the prior polio history, the stable period, and the new symptom onset, the coding follows naturally and the claim holds up to audit.

Pabau’s compliance management tools help practices build Type 1 Excludes checks, documentation prompts, and claim review checkpoints directly into clinical workflows, so G14 submissions go out clean and audit-ready on the first pass. To see how Pabau supports neurology and rehabilitation practices, book a demo.

Continue your research

Continue your research

Need structured patient record templates for complex neurological diagnoses? Pabau’s client record management supports structured problem-list entries and longitudinal documentation for conditions like postpolio syndrome.

Managing compliance documentation across a rehabilitation or physiotherapy team? Mandatory compliance for physiotherapy clinics covers the documentation standards that apply across the practice.

Looking for a neurology or rehabilitation-focused practice management platform? Pabau’s physical therapy EMR is built for multi-disciplinary teams managing patients with complex, longitudinal diagnoses.

Frequently asked questions

What is ICD-10 Code G14?

ICD-10 Code G14 is the billable ICD-10-CM diagnosis code for postpolio syndrome (PPS), classified under systemic atrophies primarily affecting the central nervous system (G10-G14). It is used when a patient with a confirmed prior history of paralytic poliomyelitis develops new neuromuscular symptoms at least 15 years after achieving clinical stability.

G14 carries a Type 1 Excludes note against B91 (sequelae of poliomyelitis), so the two codes are never reported together.

What is the difference between G14 and B91 for polio-related diagnoses?

G14 identifies active postpolio syndrome — new or worsening neuromuscular symptoms in a prior polio patient — while B91 identifies stable sequelae of the original poliomyelitis infection. The two codes carry a Type 1 Excludes relationship and must never be reported together.

Use B91 alone when the patient has stable residual effects from prior polio without new progressive symptoms; use G14 alone once the patient meets the full PPS diagnostic criteria.

Is G14 a billable ICD-10 code?

Yes. ICD-10 Code G14 is a billable and specific diagnosis code valid for reimbursement as a principal or secondary diagnosis on claims with service dates on or after October 1, 2015. It has remained active and unchanged through the 2026 ICD-10-CM update cycle.

G14 carries a Type 1 Excludes note against B91, so the two codes must never appear together on the same claim.

What are the documentation requirements for postpolio syndrome coding?

Documentation must confirm a prior history of symptomatic poliomyelitis, a stable period of at least 15 years between the original infection and new symptom onset, the specific new symptoms (muscle weakness, fatigue, pain, breathing changes), and the clinician’s reasoning excluding other causes.

This documentation is required at the initial diagnosis and should be updated at each relevant encounter to support audit review.

What was the ICD-9 equivalent of G14?

The approximate ICD-9-CM equivalent of G14 is code 138 (late effects of acute poliomyelitis). The crosswalk is approximate because ICD-9 code 138 covered a broader range of late polio effects, while ICD-10 G14 specifically designates the active syndrome with new progressive neuromuscular symptoms. Code 138 is no longer valid for claims with service dates on or after October 1, 2015.

×